Taken together, these data describe tumor- and lung-pertinent expression patterns of the major SARS-CoV-2 receptor ACE2 and priming proteases TMPRSS2 and TMPRSS4 in LUAD patients. This evidence concerns the gene TMPRSS2 and neoplasm.